0
Your cart

Your cart is empty

Browse All departments
  • All departments
Price
  • R1,000 - R2,500 (3)
  • R2,500 - R5,000 (4)
  • -
Status
Brand

Showing 1 - 7 of 7 matches in All departments

Transplantation in Hematology and Oncology II (Paperback, Softcover reprint of the original 1st ed. 2003): Wolfgang E. Berdel,... Transplantation in Hematology and Oncology II (Paperback, Softcover reprint of the original 1st ed. 2003)
Wolfgang E. Berdel, H. Jurgens, T. Buchner, J. Ritter, J. Kienast, …
R3,810 Discovery Miles 38 100 Ships in 7 - 11 working days

Hematopoietic stem cell and immune cell transplantation has cont- ued as a promising therapeutic alternative and a fascinating area of cell biology as well as a field of persistent procedural problems. This - plains why substantial parts of basic research on cell growth and d- ferentiation, immune tolerance and antitumor effects, gene transfer, minimal residual disease and supportive care have settled around cli- cal transplantation in hematology and oncology. This second volume again updates the current role of allogeneic and autologous transpl- tation in leukemias, lymphomas and solid cancers, including cont- versial strategies and novel experimental approaches. In particular, cellular immune therapy, new conditioning strategies, mismatched donor transplantation, updated clinical transplantation, antiangiogenesis and strategies against fungal infections are focused upon. Outstanding representatives of leading groups guarantee fir- hand information and indicate how we can work and cooperate more effectively to the benefit of our patients. The editors are indebted to the Gesellschaft zur Bekampfung der Krebskrankheiten Nordrhein-Westfalen for a substantial support of the publication. They also acknowledge the major contribution of Beate Kosel as coordinator of the editorial work."

Acute Leukemias VIII - Prognostic Factors and Treatment Strategies (Paperback, Softcover reprint of the original 1st ed. 2001):... Acute Leukemias VIII - Prognostic Factors and Treatment Strategies (Paperback, Softcover reprint of the original 1st ed. 2001)
T. Buchner, W. Hiddemann, B. Woermann, G. Schellong, J. Ritter, …
R1,869 Discovery Miles 18 690 Ships in 7 - 11 working days

Since 1987 Acute Leukemias (AL) has regularly reported on the state of the art in the rapidly growing, successful and exciting field of biology and management of these diseases. In this volume large multicenter clinical trials again form the solid basis for the investigation of leukemic cell biology, the detection of biologic subgroups, their differential response to alternative treatment strategies and the further development of therapy. In particular, this volume addresses mechanisms of chromosomal translocations and transcription factors, risk-adapted treatment strategies, differentiation therapy, secondary AL, special aspects in older patients, and adoptive immunotherapy. Besides the antileukemic approaches, supportive treatment with new antimicrobial substances and growth factors is updated. As a forum of worldwide activities in the field of AL this volume contains both exhaustive overviews on major clinical issues and preliminary data and hypotheses not previously published.

Transplantation in Hematology and Oncology (Paperback, Softcover reprint of the original 1st ed. 2000): T. Buchner, H. Jurgens,... Transplantation in Hematology and Oncology (Paperback, Softcover reprint of the original 1st ed. 2000)
T. Buchner, H. Jurgens, W.E. Berdel, J Van De Loo, J. Ritter, …
R2,996 Discovery Miles 29 960 Ships in 7 - 11 working days

Some three decades after bone marrow transplantation was introduced in the field of hematology and oncology, transplantation today continues to rapidly grow and expand into a variety of new modalities. Peripheral blood has been established as an effective source of autologous progenitor cells. Furthermore, the graft-versus-leukemia effect has resulted in novel strategies of adoptive immunotherapy for cancer. Finally, approaches to gene transfer and therapy are utilizing transplantation methodologies and can augment their effects. Current results, new developments and perspectives are presented in this volume. Conventional and innovative experimental approaches, the past and the future of bone marrow transplantation are reviewed and discussed by leading representatives.

Transplantation in Hematology and Oncology II (Hardcover, 2nd 2003 ed.): W.E. Berdel, H. Jurgens, T. Buchner, J. Ritter, J.... Transplantation in Hematology and Oncology II (Hardcover, 2nd 2003 ed.)
W.E. Berdel, H. Jurgens, T. Buchner, J. Ritter, J. Kienast, …
R4,783 Discovery Miles 47 830 Ships in 7 - 11 working days

Transferring hematopoietic stem cells and immune cells has continued to be a promising therapeutic alternative and a fascinating area of cell biology as well as a field of persistent procedural problems. This explains why substantial parts of basic research on cell growth and differentiation, immune tolerance and antitumor effects, gene transfer, minimal residual disease and supportive care have settled around clinical transplantation in hematology and oncology. This second volume updates the current role of allogeneic and autologous transplantation in leukemias, lymphomas and solid cancers, including controversial strategies and novel experimental approaches. Outstanding representatives of leading groups guarantee first-hand information and indicate how we can work and cooperate more effectively to the benefit of our patients.

Acute Leukemias - Pharmacokinetics and Management of Relapsed and Refractory Disease (Paperback): W. Hiddemann, T. Buchner, W.... Acute Leukemias - Pharmacokinetics and Management of Relapsed and Refractory Disease (Paperback)
W. Hiddemann, T. Buchner, W. Plunkett, M. Keating, B. Woermann, …
R2,449 Discovery Miles 24 490 Ships in 7 - 11 working days

Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven- information. Hence, it was felt that a spe- ties by the introduction of intensive combi- cial series of symposia should be devoted to nation regimens, therapeutic progress has "Pharmacokinetics and Management of slowed down and the impression of stagna- Relapsed and Refractory Disease" comple- menting the established meetings on "Prog- tion may even have occured. In contrast, the knowledge about the biology of leu- nostic Factors and Treatment Strategies" kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come "ACUTE LEUKEMIAS - Pharmacokine- from a better understanding of the pharma- tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto- Refractory Disease" to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration- for the closing distance between countries al. These achievements need to be comple- and the development of effective world- mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D.

Acute Leukemias IV - Prognostic Factors and Treatment Strategies (Paperback, Softcover reprint of the original 1st ed. 1994):... Acute Leukemias IV - Prognostic Factors and Treatment Strategies (Paperback, Softcover reprint of the original 1st ed. 1994)
T. Buchner, W. Hiddemann, B. Woermann, G. Schellong, J. Ritter
R2,731 Discovery Miles 27 310 Out of stock

The rates of acute leukemia cure have gradually improved over the last decade. Clinical study results reflect the impact of chemotherapy intensity and duration, the role of prolonged maintenance, intensified consolidation or very early intensification. Further progress has also been achieved in bone marrow trans plantation, and recent prospective studies and meta-analyses have contributed comparisons of the high antileukemic efficacy of bone marrow transplantation to that of improved chemotherapy. This allows a more successful combining of the two forms of treatment. New prognostic factors have emerged from both cytogenetic and molecular genetic research. Thus, the Philadelphia chromosome translocation and the bcr/abl gene rearrangement have proven to be the dominating risk factor in acute lymphoblastic leukemia. Since the frequency increases with age, differences in prognosis between children and adults can be explained. Evaluation of molecular and immunologic leukemia cell markers has provided a better understanding of residual leukemia in clinical remission, as a prognostic factor and in monitoring the effectiveness of the antileukemic strategy. Recent work on leukemic cell biology has resulted in novel therapeutic approaches such as terminal differentiation by all-trans-retinoic acid, modulation of chemotherapy by hematopoietic growth factors such as GM-CSF and enhancement of immunologic control by cytokines such as interleukin 2. New antimicrobial drugs and the application of mostly empiric anti-infectious strategies have helped reducing the therapeutic risk. Thus, a number of recent achievements have provided us with new options in the management of patients with acute leukemias."

Therapie des Mammakarzinoms (German, Paperback): T. Buchner, D Urbanitz, J Van De Loo Therapie des Mammakarzinoms (German, Paperback)
T. Buchner, D Urbanitz, J Van De Loo; Contributions by K.W. Brunner, H.-P. Heilmann, …
R1,496 Discovery Miles 14 960 Out of stock

palliativem Anspruch - stiitzt sich stark auf die Ergebnisse vergleichender Therapiestudien mit Berucksichtigung der Krankheitsstadien und prognostischen Faktoren.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Loot
Nadine Gordimer Paperback  (2)
R336 R283 Discovery Miles 2 830
AVENT Ultra Soft Soother (Birth - 6…
R199 Discovery Miles 1 990
Loot
Nadine Gordimer Paperback  (2)
R336 R283 Discovery Miles 2 830
JBL C100SI Headset In-ear Black
 (3)
R149 R129 Discovery Miles 1 290
Happy Baby Stage 2 - Apples, Oats…
R38 Discovery Miles 380
Hitman III
R1,299 R1,189 Discovery Miles 11 890
Casals 1800W High Pressure Washer with…
R2,995 R1,999 Discovery Miles 19 990
Carolina Herrera 212 Sexy Eau De Parfum…
R1,215 R1,102 Discovery Miles 11 020
3-Ply Disposable Face Mask (Pack of 50)
R799 R699 Discovery Miles 6 990
Sylvanian Families - Country Tree School
 (7)
R2,369 Discovery Miles 23 690

 

Partners